<html><head></head><body><h1>Tricitrasol</h1><p class="drug-subtitle"><b>Generic Name:</b> trisodium citrate dihydrate<br/>
<b>Dosage Form:</b> extracorporeal solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="First"><span class="Bold">ANTICOAGULANT SODIUM CITRATE CONCENTRATE – 46.7% Trisodium Citrate<br/>
PN 6030, 30 mL<br/>
NDC 23731-6030-3</span></p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li class="ddc-toggle-hidden">Drug Interactions</li>
<li class="ddc-toggle-hidden">Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">References</li>
</ul><h2>Tricitrasol Description</h2><p class="First"><span class="Italics">Tricitrasol</span><span class="Sup">®</span> Anticoagulant Sodium Citrate Concentrate, 46.7% Trisodium Citrate, is a sterile, non-pyrogenic solution of Trisodium Citrate (Dihydrate), USP.</p><p>Each 30 mL of <span class="Bold">concentrate</span> contains:</p><p>pH adjusted with Citric Acid</p><p>pH: 6.3 – 6.6</p><p>Single patient use only, on a single occasion.</p><h2>Tricitrasol - Clinical Pharmacology</h2><p class="First">A sodium citrate solution acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium; thus, the calcium ion is unavailable to the coagulation system <span class="Sup">1</span>.</p><h2>Indications and Usage for Tricitrasol</h2><p class="First"><span class="Italics">Tricitrasol</span><span class="Sup">®</span> Anticoagulant Sodium Citrate Concentrate, 46.7% Trisodium Citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). Just prior to performing granulocytapheresis, aseptically add 30 mL of <span class="Italics">Tricitrasol</span><span class="Sup">®</span> to 500 mL of the 6% solution of Hydroxyethyl Starch (HES), e.g. Hespan <span class="Sup">® 2-8</span>. Agitate the resultant solution for 1 minute to assure a uniform concentration of anticoagulant. The resultant solution of <span class="Italics">Tricitrasol</span><span class="Sup">®</span> and 6% solution of HES contains the following concentration depending upon the volume used:</p><p>The <span class="Italics">Tricitrasol</span><span class="Sup">®</span>/HES solution is stable for up to 24 hours at room temperature after mixing.</p><p>Refer to the manufacturer's Operator's Manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure.</p><h2>Contraindications</h2><p class="First">NOT FOR DIRECT INTRAVENOUS INFUSION.</p><h2>Warnings</h2><p class="First"><span class="Bold">CONCENTRATED ANTICOAGULANT – DILUTE PRIOR TO USE.</span></p><h2>Precautions</h2><h3>General</h3><p class="First">Aseptic technique must be maintained at all times.</p><p><span class="Italics">Tricitrasol</span><span class="Sup">®</span> Anticoagulant Sodium Citrate Concentrate is a clear/colorless solution. If the product shows any cloudiness or turbidity, the concentrate should be discarded.</p><p>The cap/stopper system provides a biological barrier and should be intact – discard product if system is comprised.</p><h3>Information for Patients</h3><p class="First">None.</p><h3>Laboratory Tests</h3><p class="First">There are no laboratory tests for the drug product at this time.</p><h3>Drug Interactions</h3><p class="First">There are no adverse reactions for the addition of the product to the rouleaux agent.</p><h3>Carcinogenesis, mutagenesis, impairment of fertility</h3><p class="First">Long-term studies in animals have not been performed to evaluate the carcinogenic potential of <span class="Italics">Tricitrasol</span><span class="Sup">®</span>.</p><h3>Pregnancy</h3><p class="First">Long-term studies in animals have not been performed to evaluate the effects of <span class="Italics">Tricitrasol</span><span class="Sup">®</span> on pregnant women.</p><h3>Pediatric Use</h3><p class="First">The safety and effectiveness of <span class="Italics">Tricitrasol</span><span class="Sup">®</span> in children have not been established.</p><h2>Adverse Reactions</h2><p class="First">Citrate reactions or toxicity may occur with the infusion of blood products containing citrate anticoagulant <span class="Sup">1. 9 11</span>. The recipient of the citrated blood product should be monitored for the signs and symptoms of citrate toxicity <span class="Sup">1. 9 11</span>. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by chills, stomach cramps, or pressure in the chest, followed by more severe reactions that are characterized by hypotension and possible cardiac arrhythmia <span class="Sup">1. 9 11</span>. Citrate toxicity may occur more frequently in patients that are hypothermic <span class="Sup">10</span>, have impaired liver or renal function <span class="Sup">10</span>, or have low calcium levels because of an underlying disease <span class="Sup">9</span>.</p><h2>Overdosage</h2><p class="First">Since the bottle of <span class="Italics">Tricitrasol</span><span class="Sup">®</span> contains only 30mL of the product, it is impossible to overdose the addition of the product to the 6% solution of HES. However, in the event of a reaction to the infusion of citrated blood products, evaluate the patient and institute appropriate corrective actions <span class="Sup">1, 9</span>.</p><h2>Tricitrasol Dosage and Administration</h2><p class="First">The apheresis system will control the amount of the citrate/6% solution of HES that is added to the whole blood and the method of administration of the solution. Refer to the Operator's Manual of the apheresis medical device.</p><h2>How is Tricitrasol Supplied</h2><p class="First"><span class="Italics">Tricitrasol</span><span class="Sup">®</span> Anticoagulant Sodium Citrate Concentrate 46.7% Trisodium Citrate</p><p class="First">It is recommended that the product be stored at ambient room temperature, 24°C (75°F); however, the product can be stored between 15°C (59°F) and 30°C (86°F). Protect from freezing and exposure to excessive heat should be minimized.</p><p class="First"><span class="Bold"><span class="Italics">Rx ONLY</span></span></p><p><span class="Italics">Tricitrasol</span><span class="Sup">®</span> is a registered trademark of Citra Labs, LLC, Braintree, MA.</p><p>Hespan <span class="Sup">®</span> is a registered trademark of B. Braun Medical, Inc., Irvine, CA.</p><h2>REFERENCES</h2><p class="First">Manufactured &amp; Distributed by: Citra Labs, LLC, 55 Messina Drive, Braintree, MA 02184 • 1-800-299-3411 or 1-781-848-2174 Fax: 1-781-848-6781</p><p>FL6030 04/13<br/>
Printed in USA</p><h2>PRINCIPAL DISPLAY PANEL - 10 Vial Case Label</h2><p class="First"><span class="Bold"><span class="Italics">Tricitrasol</span></span><span class="Sup">®</span></p><p><span class="Bold">ANTICOAGULANT SODIUM CITRATE CONCENTRATE<br/>
46.7% Trisodium Citrate<br/>
PN 6030 - 30 mL<br/>
WARNING: CONCENTRATED ANTICOAGULANT<br/>
Dilute prior to use<br/>
NOT FOR DIRECT INTRAVENOUS INFUSION</span></p><p><span class="Bold">THIS CARTON CONTAINS<br/>
10 Sterile Units - 30 mL each</span></p><p>Used with 6% Hydroxyethyl Starch 500 mL (diluent) for the Collection of<br/>
Granulocytes by Apheresis. Do not use for other anticoagulant purposes.<br/>
See package insert for directions for use.</p><p><span class="Bold">Manufactured &amp; Distributed by:</span><br/>
<span class="Bold"><span class="Italics">Citra</span></span> Labs™<br/>
55 Messina Drive, Braintree, MA 02184 • USA<br/>
Phone Number: 1-800-299-3411<br/>
Fax Number: 781-848-6781</p><p>Sterile ■ Non-Pyrogenic</p><p>Composition per 30 mL of Concentrate:<br/>
Trisodium Citrate (Dihydrate), USP      14.0 g<br/>
(pH adjusted with Citric Acid)</p><p>CAUTION: Single Procedure Use - Discard Unused Portion<br/>
Do Not Use Unless Solution is Clear and Seal is intact<br/>
Store Between 15°C - 30° C (59° F - 86° F)</p><p><span class="Bold">Rx only</span></p><p><span class="Bold">Exp:</span></p><p><span class="Bold">Lot:</span></p><p>LA6030-10B 5/15</p><h2>More about Tricitrasol (sodium citrate)</h2><ul class="more-resources-list more-resources-list-general">
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: laxatives</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>GERD</li>
<li>Indigestion</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>